NIH reported early results show benefit of remdesivir for COVID-19
On Jun. 2, 2020, the National Institutes of Health (NIH) reported that early results showed that remdesivir benefited…
-
-
FDA cleared IND for iNKT Cells to treat COVID-19 patients
On Jun. 2, 2020, Agenus announced the U.S. Food and Drug Administration’s (FDA) clearance of AgenTus’ IND application…
-
Pfizer established $500 million program to support continued biotechnology innovation
On Jun. 2, 2020, Pfizer announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will…
-
The USDA announced the first confirmed case of a dog in the U.S. to test positive for SARS-CoV-2
On Jun. 2, 2020, The U.S. Department of Agriculture’s (USDA) National Veterinary Services Laboratories announced that it found…
-
Trevena announced collaboration with Imperial College London to evaluate TRV027 in COVID-19 patients
On Jun. 2, 2020, Trevena announced it had entered into a collaboration with Imperial College London to evaluate…
-
Resverlogix announced COVID-19 clinical trial program launch
On Jun. 1, 2020, Resverlogix announced that it is moving forward with a plan to further evaluate apabetalone’s…
-
Biotechnology | Diagnostics | Infectious Disease | Measles | Vaccine | WHO
New Ebola outbreak detected in northwest Democratic Republic of the Congo
On Jun. 1, 2020,The Government of the Democratic Republic of the Congo announced that a new outbreak of…
-
Gilead announced results from phase 3 trial of Remdesivir in patients with moderate COVID-19
On Jun. 1, 2020, Gilead Sciences announced topline results from the Phase 3 SIMPLE trial in hospitalized patients…
-
Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturing
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
-
Anixa Biosciences and OntoChem synthesized four potential Covid-19 drugs for testing in biological assays
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced that the Company, together with partner OntoChem GmbH, has…
-
The USDA announced transition to preventive plan for virulent Newcastle disease in California
On Jun. 1, 2020, the U.S. Department of Agriculture (USDA) and the U.S. Department of Agriculture (USDA) announced…
-
Eli Lilly began world’s first study of a potential COVID-19 antibody treatment in humans
On Jun. 1, 2020, Eli Lilly announced patients have been dosed in the world’s first study of a…
-
Proteostasis Therapeutics announced in vitro data for PTI-129 as potential treatment candidate for COVID-19
On Jun. 1, 2020, Proteostasis Therapeutics announced results from in vitro studies evaluating the use of PTI-129 as…
-
FDA issued Emergency Use Authorization for Impella RP as therapy for COVID-19 patients with right heart failure
On Jun. 1, 2020, the Food and Drug Administration (FDA) announced it had issued an emergency use authorization…
-
Altimmune launched clinical trial of T-COVIDTM, an investigational intranasal immune modulator for treatment of patients with early COVID-19
On Jun. 1, 2020, Altimmune announced the U.S. Food and Drug Administration (FDA) had authorized the Company to…
-
LabCorp launched new COVID-19 clinical trial site to connect patients with U.S. research trials
On Jun. 1, 2020, LabCorp announced that Covance, its drug development business, had created COVID-19 Clinical Trial Connect…
-
FDA authorized OPKO Health clinical trial evaluating RAYALDEE in COVID-19 patients
On Jun. 1, 2020, OPKO Health announced the U.S. Food and Drug Administration (FDA) had authorized OPKO to…
-
Tonix Pharma announced FUJIFILM Diosynth Biotechnologies to be Manufacturing partner for COVID-19 vaccine candidate TNX-1800
On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…
-
Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccines
On May 31, 2020, Cytiva announced their Fast Trak process development team will use their expertise to develop…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | Vaccine | WHO
International community rallied to support open research and science to fight COVID-19
On May 29, 2020, the World Health Organization (WHO) announced that thirty countries and multiple international partners and…
-
The FDA streamlined development of tests with at-home sample collection
On May 29, 2020, the U.S. Food and Drug Administration (FDA) took steps to further support the development…
-
Oxford Foundry announced four new innovations for COVID-19 recovery
On May 29, 2020, the Oxford Foundry announced support of four new innovative solutions for the OXFO COVID-19…
-
CIRM board approved three projects targeting COVID-19
On May 29, 2020, the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs…
-
Moderna announced first participants in each age cohort dosed in phase 2 study of mRNA vaccine against novel Coronavirus
On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…
-
Johnson & Johnson received positive CHMP opinion for Janssen’s investigational preventive Ebola vaccine regimen
On May 29, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…
-
The US Dept of Defense launched effort to collect COVID-19 convalescent plasma
On May 29, 2020, U.S. Department of Defense (DoD) announced it had begun an effort to collect 8,000…
-
Biogen and MIT launched virtual learning lab for high school students historically underrepresented in science
On May 28, 2020, Biogen and the Lemelson-MIT Program (LMIT) at the Massachusetts Institute of Technology announced the…
-
Vaxxas announced that Merck exercised option to apply novel immune system activation platform for Vaccine candidate
On May 28, 2020, Vaxxas announced that Merck had exercised its option to utilize Vaxxas’ proprietary High Density…
-
FDA authorized Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for emergency use
On May 28, 2020, Quest Diagnostics announced it had received emergency use authorization (EUA) from the U.S. Food…
-
Roche initiated phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia
On May 28, 2020, Roche announced it had initiated of a global phase III, randomised, double-blind, multicentre study…
